Adjudera

Awarded

RYSTIGGO 140 MG/ML SOLUCION INYECTABLE, 1 vial de 3 ml

Track this recordFree account — get alerted when a contract here runs out.
Buyer
HOSPITAL CLINICO SAN CARLOS
Winners
UCB PHARMA S.A.
Contract value
€296,836
Bids received
1
Published
3 Sept 2026
Awarded
28 Aug 2026
Contract start
28 Aug 2026
Contract end
29 Aug 2027estimated
Sector
Medical equipment and pharmaceuticals
Region
Madrid
Source
Original notice on TED (611222-2026)

More awards from this buyer

AwardedBuyerWinnerContract valuePublished
SUMINISTRO, INSTALACIÓN Y PUESTA EN FUNCIONAMIENTO DE LA INFRAESTRUCTURA SUSPENDIDA Y DE LOS SISTEMAS DE INTEGRACIÓN PARA EL NUEVO BLOQUE QUIRÚRGICO DE CIRUGÍA MAYOR AMBULATORIA, EN EL HOSPITAL CLÍNICO SAN CARLOS DE MADRIDHOSPITAL CLINICO SAN CARLOSPRIM, S.A.€2,334,89616 Sept 2026
RYSTIGGO 140 MG/ML SOLUCION INYECTABLE, 1 vial de 2 mlHOSPITAL CLINICO SAN CARLOSUCB PHARMA S.A.€65,9373 Sept 2026
BRIVIACT 10 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION 5 MLHOSPITAL CLINICO SAN CARLOSUCB PHARMA S.A.€69,930RV3 Sept 2026
BRIVIACT 10 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION 5 MLHOSPITAL CLINICO SAN CARLOSUCB PHARMA S.A.€69,930RV3 Sept 2026
ABILIFY MAINTENA 720 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADAHOSPITAL CLINICO SAN CARLOSOTSUKA PHARMACEUTICAL S.A.€60,7371 Sept 2026
ABILIFY MAINTENA 960 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADAHOSPITAL CLINICO SAN CARLOSOTSUKA PHARMACEUTICAL S.A.€40,4911 Sept 2026